Hostname: page-component-84b7d79bbc-tsvsl Total loading time: 0 Render date: 2024-07-29T21:05:56.170Z Has data issue: false hasContentIssue false

Antpsychotics and CVD risk managment in rehabilitation inpatients - findings of an audit

Published online by Cambridge University Press:  16 April 2020

M.M. Paul
Affiliation:
Rehabilitation Psychiatry, Chester-le-Street, UK
M. Young
Affiliation:
Tees, Esk and Wear Valley NHS Foundation Trust, Chester-le-Street, UK
B. Wilkinson
Affiliation:
Tees, Esk and Wear Valley NHS Foundation Trust, Chester-le-Street, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Patients with severe mental illness are at increased risk of cardiovascular disease because of lifestyle, co-morbidity and medication effects.

Aim/objectives

The aim of this audit is to ascertain the regularity of metabolic health checks, CVD risk assessment and adequate lipid modification therapy among patients on antipsychotic medication in 3 rehabilitation wards in county Durham and Darlington.

Method

According to audit standards (based on NICE guidelines-Schizophrenia, Lipid Modification, Maudsley guidelines), All patients should have Blood Pressure, Body Mass Index (BMI), CVD risk assessment using appropriate calculator, Fasting blood glucose and Fasting Lipid profile done at least once a year. Lipid modification therapy has to be offered to those with 10 year CVD risk of 20% or greater. All 31 patients in 3 rehabilitation wards were included. We searched for these readings between 1/09/2010 to 30/08/2010 in patient records.

Results

Of 31 patients, 26(84%) had blood pressure, 29(94%) had BMI and 11(35%) had either fasting blood sugar or HbA1c recorded. CVD risk assessment using calculator was not done in any patients. 19(61%) lipid profile done. Of the 19 patients 16 (84%) had abnormal lipid profile. 9 (26%) patients were on lipid modifying drugs, 6 (19%) patients were on appropriate dose of lipid modifying drugs.

Conclusion

Our audit identified a need for systemic assessment of physical health with emphasis on cardiovascular risk management (lifestyle education, lipid modification therapy) which are critical to minimising risks and preventing long term adverse health consequences.

Type
P03-302
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.